About Kurt Gehlsen
Form D filings for Spiro Medical in 2024 list Kurt Gehlsen as executive officer.
Form D filings also name Kurt Gehlsen as an executive officer and director at NOXX Therapeutics.
Kurt Gehlsen first appears on SEC filings in 2023.
Experience
This experience comes from Kurt Gehlsen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kurt Gehlsen in the role, so the role may have started earlier or lasted longer.
NOXX Therapeutics, Inc. Current
Executive officer
Founder, Chairman, CEO (2023 – Present)
2023 – Present · Boca Raton, FL
GC
Gehlsen Consulting Current
Founder
2018 – Present
BI
Biorasi
Vice President and Chief Scientific Officer
2019 – 2020
RT
Research Corporation Technologies
VP and CSO
2005 – 2018
MI
Maxim Pharmaceuticals, Inc.
Senior VP and CSO
1996 – 2004
SJ
Sidney Kimmel Cancer Center – La Jolla
Associate Member
1996 – 2002
CR
California Institute for Biological Research
Associate Member
1991 – 1996
TI
Trauma Products, Inc
President and CEO
1991 – 1995
PA
Pharmacia, AB.
Research Head, Experimental Medicine
1989 – 1993
LM
La Jolla Institute for Experimental Medicine
Founder and COO
1989 – 1991
Key Colleagues at Startups
The people Kurt Gehlsen works with at each company, as listed on that company's latest Form D.
NOXX Therapeutics, Inc. · Form D, Mar 31, 2026
Spiro Medical Inc. · Form D/A, Jun 6, 2024
BM
Brian Mooney
CFO and director